Literature DB >> 24799473

Predictive value of the international association for the study of lung cancer/American Thoracic Society/European Respiratory Society classification of lung adenocarcinoma in tumor recurrence and patient survival.

Jung-Jyh Hung1, Yi-Chen Yeh1, Wen-Juei Jeng1, Kou-Juey Wu1, Biing-Shiun Huang1, Yu-Chung Wu1, Teh-Ying Chou1, Wen-Hu Hsu2.   

Abstract

PURPOSE: This study investigated the pattern of recurrence of lung adenocarcinoma and the predictive value of histologic classification in resected lung adenocarcinoma using the new International Association for the Study of Lung Cancer (IASLC)/American Thoracic Society (ATS)/European Respiratory Society (ERS) classification system. PATIENTS AND METHODS: Histologic classification of 573 patients undergoing resection for lung adenocarcinoma was determined according to the IASLC/ATS/ERS classification system, and the percentage of each histologic component (lepidic, acinar, papillary, micropapillary, and solid) was recorded. The pattern of recurrence of those components and their predictive value were investigated.
RESULTS: The predominant histologic pattern was significantly associated with sex (P < .01), invasive tumor size (P < .01), T status (P < .01), N status (P < .01), TNM stage (P < .01), and visceral pleural invasion (P < .01). The percentage of recurrence was significantly higher in micropapillary- and solid-predominant adenocarcinomas (P < .01). Micropapillary- and solid-predominant adenocarcinomas had a significantly higher possibility of developing initial extrathoracic-only recurrence than other types (P < .01). The predominant pattern group (micropapillary or solid v lepidic, acinar, or papillary) was a significant prognostic factor in overall survival (OS; P < .01), probability of freedom from recurrence (P < .01), and disease-specific survival (P < .01) in multivariable analysis. For patients receiving adjuvant chemotherapy, solid-predominant adenocarcinoma was a significant predictor for poor OS (P = .04).
CONCLUSION: In lung adenocarcinoma, the IASLC/ATS/ERS classification system has significant prognostic and predictive value regarding death and recurrence. Solid-predominant adenocarcinoma was also a significant predictor in patients undergoing adjuvant chemotherapy. Prognostic and predictive information is important for stratifying patients for aggressive adjuvant chemoradiotherapy.
© 2014 by American Society of Clinical Oncology.

Entities:  

Mesh:

Year:  2014        PMID: 24799473     DOI: 10.1200/JCO.2013.50.1049

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  77 in total

1.  Micropapillary and/or Solid Histologic Subtype Based on Pre-Treatment Biopsy Predicts Local Recurrence After Thermal Ablation of Lung Adenocarcinoma.

Authors:  Song Gao; Seth Stein; Elena N Petre; Waleed Shady; Jeremy C Durack; Carole Ridge; Prasad Adusumilli; Natasha Rekhtman; Stephen B Solomon; Etay Ziv
Journal:  Cardiovasc Intervent Radiol       Date:  2017-08-02       Impact factor: 2.740

2.  Comprehensive Computed Tomography Radiomics Analysis of Lung Adenocarcinoma for Prognostication.

Authors:  Geewon Lee; Hyunjin Park; Insuk Sohn; Seung-Hak Lee; So Hee Song; Hyeseung Kim; Kyung Soo Lee; Young Mog Shim; Ho Yun Lee
Journal:  Oncologist       Date:  2018-04-05

3.  Clinicopathologic correlates of postoperative N1 or N2 nodal upstaging in non-small cell lung cancer.

Authors:  Youngkyu Moon; Kyo Young Lee; Kyung Soo Kim; Jae Kil Park
Journal:  J Thorac Dis       Date:  2016-01       Impact factor: 2.895

Review 4.  Expanding anaplastic lymphoma kinase therapeutic indication to early stage non-small cell lung cancer.

Authors:  Fabrizio Tabbò; Silvia Novello
Journal:  Transl Lung Cancer Res       Date:  2019-11

5.  Genomic Landscape and Immune Microenvironment Features of Preinvasive and Early Invasive Lung Adenocarcinoma.

Authors:  Chao Zhang; Jianjun Zhang; Fang-Ping Xu; Yin-Guang Wang; Zhi Xie; Jian Su; Song Dong; Qiang Nie; Yang Shao; Qing Zhou; Jin-Ji Yang; Xue-Ning Yang; Xu-Chao Zhang; Zhi Li; Yi-Long Wu; Wen-Zhao Zhong
Journal:  J Thorac Oncol       Date:  2019-08-22       Impact factor: 15.609

6.  Histologic subtype component predicts lymph node micrometastasis and prognosis in patients with stage I lung adenocarcinoma.

Authors:  Jung-Jyh Hung
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

7.  Micropapillary histological subtype in lung adenocarcinoma of 2 cm or less: impact on recurrence and clinical predictors.

Authors:  Yukihiro Yoshida; Jun-Ichi Nitadori; Aya Shinozaki-Ushiku; Jiro Sato; Tempei Miyaji; Takuhiro Yamaguchi; Masashi Fukayama; Jun Nakajima
Journal:  Gen Thorac Cardiovasc Surg       Date:  2017-02-27

8.  Does the histologic predominance of pathological stage IA lung adenocarcinoma influence the extent of resection?

Authors:  Hiroyuki Ito; Haruhiko Nakayama; Shuji Murakami; Tomoyuki Yokose; Kayoko Katayama; Yoshihiro Miyata; Morihito Okada
Journal:  Gen Thorac Cardiovasc Surg       Date:  2017-06-07

9.  The new IASLC-ATS-ERS lung adenocarcinoma classification: what the surgeon should know.

Authors:  Takashi Eguchi; Kyuichi Kadota; Bernard J Park; William D Travis; David R Jones; Prasad S Adusumilli
Journal:  Semin Thorac Cardiovasc Surg       Date:  2014-09-16

10.  Prognostic value of the IASLC/ATS/ERS classification and IMP3 expression in lung adenocarcinoma of Chinese cases.

Authors:  Xiangjie Sun; Ping Wei; Chen Shen; Yusi Yang; Yiqin Wang; Yuan Li; Xiang Du
Journal:  Am J Cancer Res       Date:  2015-06-15       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.